Results 21 to 30 of about 9,546,471 (324)

Label-free proteomics identifies Calreticulin and GRP75/Mortalin as peripherally accessible protein biomarkers for spinal muscular atrophy [PDF]

open access: yes, 2013
BACKGROUND: Spinal muscular atrophy (SMA) is a neuromuscular disease resulting from mutations in the survival motor neuron 1 (SMN1) gene. Recent breakthroughs in preclinical research have highlighted several potential novel therapies for SMA, increasing ...
Gillingwater, T. H.   +4 more
core   +3 more sources

Seronegative fibrosing cholestatic hepatitis С after liver retransplantation for unresectable neuroendocrine tumor liver metastases

open access: yesТрансплантология (Москва), 2020
We present an uncommon case of liver graft dysfunction caused by seronegative hepatitis C-related fibrosing cholestatic hepatitis after cadaver liver transplantation for unresectable liver metastases of neuroendocrine small intestine cancer followed by ...
S. E. Voskanyan   +9 more
doaj   +1 more source

Behavior and application of self-centering dampers equipped with buckling-restrained SMA bars

open access: yesSmart materials and structures (Print), 2020
This study proposes a new type of self-centering damper equipped with novel buckling-restrained superelastic shape memory alloy (SMA) bars. The new solution aims to address some critical issues related to degradation and loss of superelasticity observed ...
C. Qiu   +4 more
semanticscholar   +1 more source

New functional nanocomposites based on poly(trimethylene 2,5-furanoate) and few layer graphene prepared by in situ polymerization

open access: yeseXPRESS Polymer Letters, 2018
Poly(trimethylene 2,5-furanoate) (PTF) nanocomposites reinforced with few layer graphene (FLG) were prepared through in situ polymerization. The method in question allows obtaining well-dispersed nanoplatelets in the whole volume of PTF matrix.
S. Paszkiewicz   +8 more
doaj   +1 more source

Age-dependent SMN expression in disease-relevant tissue and implications for SMA treatment.

open access: yesJournal of Clinical Investigation, 2019
BACKGROUNDSpinal muscular atrophy (SMA) is caused by deficient expression of survival motor neuron (SMN) protein. New SMN-enhancing therapeutics are associated with variable clinical benefits.
Daniel M. Ramos   +21 more
semanticscholar   +1 more source

Electrocardiographic (ECG) criteria for determining left ventricular mass in young healthy men; data from the LARGE Heart study [PDF]

open access: yes, 2009
Background: Doubts remain over the use of the ECG in identifying those with increased left ventricular (LV) mass. This is especially so in young individuals, despite their high prevalence of ECG criteria for LV hypertrophy.
Montgomery, HE   +5 more
core   +2 more sources

Bilateral segmentectomies using virtual-assisted lung mapping (VAL-MAP) for metastatic lung tumors

open access: yesSurgical Case Reports, 2017
Background Virtual-assisted lung mapping (VAL-MAP) has been used not only in wedge resection but also in segmentectomy for hardly palpable lung nodules.
Keita Nakao   +3 more
doaj   +1 more source

Restoration of SMN in Schwann cells reverses myelination defects and improves neuromuscular function in spinal muscular atrophy [PDF]

open access: yes, 2016
Spinal muscular atrophy (SMA) is a neuromuscular disease caused by low levels of SMN protein, primarily affecting lower motor neurons. Recent evidence from SMA and related conditions suggests that glial cells can influence disease severity.
Brophy, Peter J.   +9 more
core   +3 more sources

Pressure-point-garments: haptic stimulation of the body enabled through a fashionable 3D-textile interface

open access: yesCommunications in Development and Assembling of Textile Products, 2023
Developments in textile and fiber engineering have allowed the development of functional clothing such as protective wear, sportswear, and medical clothing.
Dominique Almendariz   +2 more
doaj  

Treatment algorithm for infants diagnosed with spinal muscular atrophy through newborn screening [PDF]

open access: yes, 2018
Spinal muscular atrophy (SMA) is an autosomal recessive disease characterized by the degeneration of alpha motor neurons in the spinal cord, leading to muscular atrophy.
Connolly, Anne   +14 more
core   +2 more sources

Home - About - Disclaimer - Privacy